查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464945

药物注射系统市场：按产品类型、应用和最终用户划分 - 全球预测 2024-2030

Drug Infusion Systems Market by Product Type (Infusion Pump, IV Disposable), Application (Diabetes, Gastrointestinal Diseases, Oncology), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年药物注射系统市场规模为226.1亿美元，2024年达240.1亿美元，预计2030年将达到355.5亿美元，复合年增长率为6.67%。

药物注射系统是先进的医疗设备，旨在以受控方式将药物输送到患者体内。这些系统旨在确保以适当的速率、剂量和时间给药，以达到预期的治疗效果。药物输注系统依其功能分为多种类型，例如连续输注帮浦、病人自控式镇痛（PCA）帮浦、合成橡胶和注射式帮浦。使用药物传递系统的主要优点是能够传递一致且准确的剂量，这对于化疗、胰岛素治疗和疼痛管理等精准强化治疗至关重要。这些系统提供了药物给药的弹性，允许根据患者的特定需求和对治疗的反应来调整给药方案和剂量。药物注射系统提高了患者的舒适度和便利性，减少了频繁的手动给药的需要，并且能够长时间控制药物输送。癌症发生率的增加、对化疗输注帮浦的需求、技术创新和先进设备的持续采用正在推动药物输注系统市场的成长。然而，在网路威胁日益增加的情况下确保输液系统的安全性和有效性是一项挑战。物联网和人工智慧在药物传输技术中的个人化医疗的广泛集成，以及对改善医疗基础设施的不断增加的投资，为市场渗透提供了广阔的前景。

主要市场统计
基准年[2023] 226.1亿美元
预测年份 [2024] 240.1亿美元
预测年份 [2030] 355.5亿美元
复合年增长率（%） 6.67%

产品类型 对慢性病的日益关注促使一次性抛弃式的使用增加

输液帮浦是一种复杂的医疗设备，旨在将受管制量的液体（包括营养物质和药物）输送到患者体内。这些泵型态多种形式，包括门诊泵、固定泵、注射泵和容积泵，每种泵都根据特定患者的需求量身定制。输液帮浦在医院环境和居家照护中都至关重要，它可以精确控制从化疗到疼痛管理等各种治疗的给药速率和体积。输液帮浦的可程式性和错误侦测警报可提高病患的安全性和治疗效果。输液抛弃式涵盖了静脉治疗中一次性使用的一大类产品。此类别包括导管、管材、针头、静脉输液袋等。静脉抛弃式旨在最大限度地降低感染风险并确保无菌，对于将药物、液体和营养物质直接注射到患者的血液中至关重要。它们在从急诊室到长期护理设施的许多医疗机构中发挥着至关重要的作用，为挽救生命的治疗提供了无菌途径。方便、安全的一次性抛弃式已成为现代医疗保健的重要组成部分。

应用 频繁使用药物输注系统以维持最佳血糖值并儘量减少糖尿病相关併发症

药物输注系统透过胰岛素帮浦治疗在糖尿病（尤其是第 1 型糖尿病）的治疗中发挥着至关重要的作用。这些设备模仿健康胰臟的胰岛素分泌，全天持续输送短效或速效胰岛素。此方法可根据血糖监测资料更准确地调整胰岛素水平，降低高血糖和低血糖的风险，从而改善血糖控制和生活品质。在克隆氏症和溃疡性大肠炎等慢性胃肠道疾病的治疗中，药物输注系统用于将生物疗法直接输送到血液中。这种输注疗法对于对标准治疗没有反应的患者更有效。此外，透过控制药物递送，可以最小化与全身给药相关的副作用。药物注射系统在肿瘤学化疗传递中非常重要，可以精确控制药物传递的速度和时间，提高治疗效果，同时最大限度地减少副作用。药物输注系统可用于连续输注化疗，这种化疗可以长时间给药，对某些类型的癌症更有效。此外，它还可以实现个人化的癌症治疗方法，并可以适应患者特定的药物治疗方案和剂量。在小儿科领域，药物注射系统透过提供适合儿童独特需求的受控和精确的药物传递而具有显着的优势。它可用于多种情况，从使用抗生素治疗感染疾病到用于癌症治疗的化疗。药物传递系统的准确性对于儿童族群至关重要，通常必须根据体重仔细计算剂量。

区域洞察

在美洲，特别是在美国和加拿大，由于糖尿病和癌症等慢性病的流行，对先进的给药系统的需求量很大。美国市场的特点是医疗保健支出高，注重先进的医疗保健解决方案，青睐智慧、连网型和可携式输液设备。加拿大有一项支持先进医疗设备的医疗保健计划。受经济差异和医疗保健获取的影响，亚太地区呈现多元化，消费者需求从基本输液系统到高级输液系统不等。由于政府推动医疗改革的倡议、医疗基础设施的投资以及不断增长的中产阶级消费者基础，中国市场正在蓬勃发展。日本在各个领域都展现出技术进步，尤其是医疗保健。由于人口老化以及对可在诊所和家庭管理的高效医疗保健解决方案的需求，日本的药物输送系统方法强调创新和易用性。由于医疗保健成本的增加和意识的提高，印度的药物注射系统市场正在成长。 MEA 地区是一个多元化的市场，拥有不同的医疗基础设施和准入水准。波湾合作理事会(GCC) 国家正在医疗保健领域进行重大投资，包括在医院和诊所采用先进的药物输注系统。由于旨在改善医疗保健和与国际组织建立伙伴关係的倡议，非洲地区的市场潜力正在逐渐增加。在欧盟国家，由于有利的医疗政策、老年人口的增加和慢性病的增加，药物输注系统的引入正在扩大。欧盟对医疗设备有严格的法规，确保高品质和安全标准。最近的投资旨在开发智慧输液系统，以提高患者的移动性和舒适度。

FPNV定位矩阵

FPNV定位矩阵对于评估药物注射系统市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对药物注射系统市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 注射系统市场的市场规模与预测是多少？

2.在药物注射系统市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.注射系统市场的技术趋势和法规结构是什么？

4.注射系统市场主要厂商的市场占有率为何？

5.进入註射系统市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症发生率增加以及化疗输注帮浦的需求
      • 增加输液帮浦的引入
      • 对高效、准确的给药系统的需求不断增长以及向家庭医疗保健的转变
    • 抑制因素
      • 采购和安装的初始成本较高
    • 机会
      • 扩大物联网和人工智慧在药物传输技术中的个人化医疗的整合
      • 加大药物注射系统的投资与研发力度
    • 任务
      • 在网路威胁日益严重的情况下确保输液系统的安全性和有效性
  • 市场区隔分析
    • 产品类型：对慢性病的持续关注正在增加一次性静脉抛弃式的使用。
    • 应用：大量使用药物输注系统以维持最佳血糖值并最大限度地减少糖尿病相关併发症
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章药物注射系统市场：依产品类型

  • 点滴帮浦
  • 抛弃式静脉注射

第七章药物注射系统市场：依应用分类

  • 糖尿病
  • 消化系统疾病
  • 肿瘤学
  • 小儿科

第八章药物注射系统市场：依最终使用者分类

  • 居家护理
  • 医院
  • 专科诊所

第九章美洲药物注射系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太药物注射系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲注射系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 费森尤斯·卡比 (Fresenius Kabi) 与梅奥诊所 (Mayo Clinic) 签署 Evenix 输液系统协议
    • Insulet 为具有可调警报限值和Bolus洩漏警报功能的输液帮浦系统申请了专利
    • Eitan Medical推出云端基础的输液管理平台
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-F97DD5A7D582

[181 Pages Report] The Drug Infusion Systems Market size was estimated at USD 22.61 billion in 2023 and expected to reach USD 24.01 billion in 2024, at a CAGR 6.67% to reach USD 35.55 billion by 2030.

Drug infusion systems are sophisticated medical devices designed to deliver drugs into a patient's body in a controlled manner. These systems are engineered to ensure that medications are administered at the proper rate, volume, and duration to achieve the intended therapeutic effect. Drug infusion systems can be classified into various types based on their functionality, including continuous infusion pumps, patient-controlled analgesia (PCA) pumps, elastomeric pumps, and syringe pumps. The core advantage of using drug infusion systems lies in their ability to provide a consistent and precise dosage of medication, which is crucial for treatments that require a high level of accuracy, such as chemotherapy, insulin therapy, and pain management. These systems offer flexibility in drug administration, allowing for adjustments in dosing schedules and amounts based on the patient's specific needs and response to treatment. Drug infusion systems enhance patient comfort and convenience, reducing the need for frequent manual drug administration and enabling controlled drug delivery over extended periods. The growing incidence of cancer, the need for chemotherapy infusion pumps, and the increasing innovation and adoption of technologically advanced devices are driving the growth of the drug infusion systems market. However, ensuring the safety and efficacy of infusion systems amid rising cyber threats is challenging. The widening integration of IoT and AI for personalized medicine in drug delivery technologies and increasing investments in improving healthcare infrastructures offer vast prospects for market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 22.61 billion
Estimated Year [2024] USD 24.01 billion
Forecast Year [2030] USD 35.55 billion
CAGR (%) 6.67%

Product Type: Increasing use of IV disposables owing to the ongoing concerns regarding chronic diseases

The infusion pumps are sophisticated medical devices designed for delivering fluids, including nutrients and medications, into a patient's body in controlled amounts. These pumps come in various forms, including ambulatory, stationary, syringe, and volumetric pumps, each tailored to specific patient needs. Infusion pumps are essential in both hospital settings and home care and offer precise control over the delivery rates and volume, accommodating a wide range of therapies, from chemotherapy to pain management. The programmability and alarms of infusion pumps for error detection enhance patient safety and treatment efficacy. IV disposables encompass a broad category of products intended for single use in intravenous therapy. This category includes catheters, tubing, needles, and IV bags. IV disposables are designed to minimize the risk of infection and ensure sterility and are crucial in administering drugs, fluids, and nutrients directly into a patient's bloodstream. They are pivotal in many medical settings, ranging from emergency rooms to long-term care facilities, providing a sterile pathway for administering life-saving treatments. The convenience and safety aspects of IV disposables make them indispensable in modern healthcare.

Application: Extensive use of drug infusion systems to maintain optimal blood glucose levels and minimize diabetes-related complications

Drug infusion systems play a pivotal role in the management of diabetes, particularly Type 1 diabetes, through insulin pump therapy. These devices continuously deliver short-acting or rapid-acting insulin throughout the day, mimicking how a healthy pancreas releases insulin. This method can improve glycemic control and quality of life by allowing more precise adjustment of insulin levels in response to glucose monitoring data, reducing both hyperglycemia and the risk of hypoglycemia. In managing chronic gastrointestinal diseases such as Crohn's disease or ulcerative colitis, drug infusion systems are utilized to administer biological therapies directly into the bloodstream. These infusion therapies are more effective for the ones who do not respond to standard treatment. Additionally, the controlled delivery of drugs can minimize side effects associated with systemic administration. Drug infusion systems are critically important in oncology for chemotherapy delivery and enable precise control over the rate and timing of drug delivery, which can enhance the efficacy of the treatment while minimizing its side effects. Drug infusion systems can be used for continuous infusion chemotherapy, where drugs are administered over a long period, which may be more effective for certain types of cancer. Furthermore, they allow for a more personalized approach to cancer treatment, accommodating patient-specific drug regimens and dosages. In pediatrics, drug infusion systems offer significant advantages by providing controlled and accurate drug delivery suitable for children's unique requirements. They are used in various scenarios, from antibiotic administration for infections to chemotherapy for cancer treatment. The precision of drug infusion systems is crucial for the pediatric population, where dosages often must be carefully calculated based on weight.

Regional Insights

In the Americas, particularly the United States and Canada, there is a high demand for advanced drug infusion systems due to the prevalence of chronic diseases, including diabetes and cancer. The U.S. market is characterized by high healthcare spending and a strong emphasis on advanced healthcare solutions, leading to a preference for smart, connected, and portable infusion devices. Canada has healthcare initiatives supporting advanced medical devices. The Asia Pacific region is diverse, with consumer needs ranging from basic to advanced infusion systems, influenced by economic disparities and healthcare access. China's market is booming due to government initiatives promoting healthcare reform, investment in healthcare infrastructure, and a growing middle-class consumer base. Japan showcases technological advancements across various sectors, with healthcare being a prime focus. Japan's approach to drug infusion systems emphasizes innovation and user-friendliness and is driven by an aging population and the necessity for efficient healthcare solutions that can be managed both in clinical settings and at home. India's drug infusion systems market is growing with increasing healthcare spending and awareness. The MEA region presents a diverse market with varying healthcare infrastructure and access levels. The Gulf Cooperation Council (GCC) countries are witnessing significant investments in healthcare, including the adoption of advanced drug infusion systems in hospitals and clinics. In the African region, initiatives aimed at healthcare improvement and partnerships with international organizations are gradually enhancing the market potential in these regions.EU countries exhibit a growing adoption of drug infusion systems, driven by favorable healthcare policies, an increase in the geriatric population, and a rise in chronic conditions. The EU has stringent regulations regarding medical devices, ensuring high quality and safety standards. Recent investments have been channeled toward developing smart infusion systems that promote patient mobility and comfort.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Infusion Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Infusion Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Infusion Systems Market, highlighting leading vendors and their innovative profiles. These include AKAS Infusions, B. Braun SE, Baxter International, Inc., Becton, Dickinson, and Company, Debiotech S.A., Eitan Medical, Flowonix Medical Inc., Fresenius Kabi AG, Fresenius SE & Co. KGaA, Halyard Health, Inc., ICU Medical Inc., Insulet Corporation, Intera Oncology Inc., IRADIMED CORPORATION, Ivenix Inc., Medtronic Plc, Micrel Medical Devices SA, Microport Scientific Corporation, MOOG, Inc., Promecon GmbH, SINO MDT, Smiths Group plc, Tandem Diabetes Care, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Infusion Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Infusion Pump
    • IV Disposable
  • Application
    • Diabetes
    • Gastrointestinal Diseases
    • Oncology
    • Pediatrics
  • End-user
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Drug Infusion Systems Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Infusion Systems Market?

3. What are the technology trends and regulatory frameworks in the Drug Infusion Systems Market?

4. What is the market share of the leading vendors in the Drug Infusion Systems Market?

5. Which modes and strategic moves are suitable for entering the Drug Infusion Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of cancer and the need for chemotherapy infusion pumps
      • 5.1.1.2. Increasing adoption of infusion pumps
      • 5.1.1.3. Rising demand for efficient and precise drug delivery systems and a shift toward home healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. High initial cost of procurement and installation
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing integration of IoT and AI for personalized medicine in drug delivery technologies
      • 5.1.3.2. Increasing investments and R&D in drug infusion system
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring safety and efficacy of infusion systems amid rising cyber threats
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing use of IV disposables owing to the ongoing concerns regarding chronic diseases
    • 5.2.2. Application: Extensive use of drug infusion systems to maintain optimal blood glucose levels and minimize diabetes-related complications
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Drug Infusion Systems Market, by Product Type

  • 6.1. Introduction
  • 6.2. Infusion Pump
  • 6.3. IV Disposable

7. Drug Infusion Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Diabetes
  • 7.3. Gastrointestinal Diseases
  • 7.4. Oncology
  • 7.5. Pediatrics

8. Drug Infusion Systems Market, by End-user

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Drug Infusion Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Infusion Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Infusion Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Fresenius Kabi, Mayo Clinic Ink Deal On Ivenix Infusion System
    • 12.3.2. Insulet Files Patent On Infusion Pump System With Adjustable Alarm Limits And Missed Bolus Alarm
    • 12.3.3. Eitan Medical Launched Cloud-Based Infusion Management Platform
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DRUG INFUSION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG INFUSION SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DRUG INFUSION SYSTEMS MARKET DYNAMICS
  • FIGURE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG INFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY IV DISPOSABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY IV DISPOSABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023